Companies / BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc.
Nasdaq: BBOTCIK 1869105SOUTH SAN FRANCISCO, CA
Financials
Ownership
80.2M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 0.15% | 116,670 |
| Institutions | 74.08% | 59,391,012 |
| Public float | 25.78% | 20,666,585 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Beltran PedroChief Scientific Officer | 0.06% | 46,670 |
Ben YongChief Med & Dev Officer | 0.06% | 46,670 |
Mehra UneekChief Financial Officer | 0.03% | 23,330 |
Lebowitz Peter FDirector | — | — |
McCormick FrankDirector | — | — |
Wallace Eli M.CEOChief Executive Officer · Director | — | — |
Institutional holders 57
View all →| Holder | Value | % of shares |
|---|---|---|
| $223.84M | 22.30% | |
| $43.72M | 6.09% | |
| $41.19M | 4.10% | |
| $36.40M | 3.63% | |
| $35.35M | 3.52% | |
| $32.89M | 3.28% | |
| $31.68M | 3.16% | |
| $31.41M | 0.51% | |
| $28.32M | 2.82% | |
| $21.51M | 3.52% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Trim | Common Stock | $-8.95M | -1.0M -71.43% | 400,000 0.50% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $6.24M | +818K +374.88% | 1,036,569 1.29% of shares | medium |
| Q1 2026 as of | Laurion Capital Management LP 13F manager | Add | Common Stock | $4.10M | +458K +31.24% | 1,922,656 2.40% of shares | low |
| Q1 2026 as of | Schroder Investment Management Group 13F manager | New | Common Stock | $2.16M | +249K | 249,161 0.31% of shares | low |
| Q1 2026 as of | Granahan Investment Management, LLC 13F manager | New | Common Stock | $2.07M | +231K | 231,040 0.29% of shares | low |
| Q1 2026 as of | Novo Holdings A/S 13F manager | Add | Common Stock | $2.01M | +225K +11.45% | 2,185,923 2.73% of shares | low |
| Q1 2026 as of | HighVista Strategies LLC 13F manager | Trim | Common Stock | $-1.35M | -151K -65.90% | 78,187 0.10% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common Stock | $984.5K | +110K | 110,000 0.14% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BBOT | Common Stock | 107924102 |